Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV

Bibliographic Details
Title: Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
Authors: Lorie Marchitto, Debashree Chatterjee, Shilei Ding, Gabrielle Gendron-Lepage, Alexandra Tauzin, Marianne Boutin, Mehdi Benlarbi, Halima Medjahed, Mohamed Sylla, Hélène Lanctôt, Madeleine Durand, Andrés Finzi, Cécile Tremblay
Source: Viruses, Vol 15, Iss 10, p 2004 (2023)
Publisher Information: MDPI AG, 2023.
Publication Year: 2023
Collection: LCC:Microbiology
Subject Terms: SARS-CoV-2, PLWH, humoral responses, antibody responses, ADCC, neutralization, Microbiology, QR1-502
More Details: While mRNA SARS-CoV-2 vaccination elicits strong humoral responses in the general population, humoral responses in people living with HIV (PLWH) remain to be clarified. Here, we conducted a longitudinal study of vaccine immunogenicity elicited after two and three doses of mRNA SARS-CoV-2 vaccine in PLWH stratified by their CD4 count. We measured the capacity of the antibodies elicited by vaccination to bind the Spike glycoprotein of different variants of concern (VOCs). We also evaluated the Fc-mediated effector functions of these antibodies by measuring their ability to eliminate CEM.NKr cells stably expressing SARS-CoV-2 Spikes. Finally, we measured the relative capacity of the antibodies to neutralize authentic SARS-CoV-2 virus after the third dose of mRNA vaccine. We found that after two doses of SARS-CoV-2 mRNA vaccine, PLWH with a CD4 count < 250/mm3 had lower levels of anti-RBD IgG antibodies compared to PLWH with a CD4 count > 250/mm3 (p < 0.05). A third dose increased these levels and importantly, no major differences were observed in their capacity to mediate Fc-effector functions and neutralize authentic SARS-CoV-2. Overall, our work demonstrates the importance of mRNA vaccine boosting in immuno-compromised individuals presenting low levels of CD4.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1999-4915
Relation: https://www.mdpi.com/1999-4915/15/10/2004; https://doaj.org/toc/1999-4915
DOI: 10.3390/v15102004
Access URL: https://doaj.org/article/bfc8eeab61784140a7f286084d74af12
Accession Number: edsdoj.bfc8eeab61784140a7f286084d74af12
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:19994915
DOI:10.3390/v15102004
Published in:Viruses
Language:English